Antidepressive Agents, Second-Generation

All categories
DBCAT000347Therapeutic category

A structurally and mechanistically diverse group of drugs that are not tricyclics or monoamine oxidase inhibitors. The most clinically important appear to act selectively on serotonergic systems, especially by inhibiting serotonin reuptake. A DrugBank category of 20 drugs. 18 of them are approved.

Also known as
Agents, Second-Generation Antidepressive · Antidepressants, Atypical · Antidepressive Agents, Second Generation · Antidepressive Drugs, Second Generation · Antidepressive Drugs, Second-Generation
Drugs

What you can answer from here — as of August 24, 2016

20DrugsEach linked to its full drug card
Listed above
61Drug targetsEvery drug–target pair in the class, with bond type
Sign in
11,899Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
9Routes of administrationHow the drugs in this class are given
Sign in

Which targets do Antidepressive Agents, Second-Generation share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In